Global /Australia /Industrials /Specialty Business Services /GSS

Genetic Signatures Ltd.

GSS

• ASX: GSS • Delayed

0.0820AUD -3.5%

0.0585 USD

As of 5 June 2026, Genetic Signatures Ltd. has a market cap of $13.78M USD, ranking #39515 globally and #1221 in Australia. It ranks #9057 in the Industrials sector, and #1143 in the Specialty Business Services industry.

Global Rank

39515

Country Rank

1221

Sector Rank

9057

Industry Rank

1143

Key Stats

Market Cap

$13.78MUSD

19.31M AUD

Enterprise Value

-$7.14MUSD

-10.0M AUD

Revenue (TTM)

$14.23MUSD

19.94M AUD

EBITDA (TTM)

-$7.44MUSD

-10.42M AUD

Net Income (TTM)

-$8.04MUSD

-11.27M AUD

EBITDA Margin

-52%

Profit Margin

-57%

PS Ratio

1.0

PB Ratio

0.4

Company Profile

Country (HQ)

Australia

Sector

Industrials

Industry

Specialty Business Services

CEO

Maria Halasz open_in_new

Founded

2001

Website

geneticsignatures.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.5%	-43%	-3.4%	-48%	-76%	-66%	-79%	-89%	-94%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	GSS Genetic Signatures Ltd ISIN: AU000000GSS4 Shares Out.: Shares Outstanding: 227.139M¹ Shares Float: 178.005M² TV: TradingView: ASX: GSS SA: Stock Analysis: ASX: GSS YF: Yahoo Finance: GSS.AX GF: Google Finance: ASX: GSS BA: Barron's: GSS MS: Morningstar: XASX: GSS	0.0820 AUD	TV: TradingView: ASX: GSS SA: Stock Analysis: ASX: GSS YF: Yahoo Finance: GSS.AX GF: Google Finance: ASX: GSS BA: Barron's: GSS MS: Morningstar: XASX: GSS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Genetic Signatures Ltd.

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

Similar Companies

Industry: Specialty Business Services (Australia)

Name	Market Cap (USD) diff.	PE	Country
Computershare Ltd. ASX: CPU	$12.26B 17.18B AUD 89K%	19.3	Australia
ALS Ltd. ASX: ALQ	$7.65B 10.72B AUD 55K%	38.6	Australia
GrainCorp Ltd. ASX: GNC	$948.52M 1.33B AUD 7K%	34.1	Australia
Service Stream Ltd. ASX: SSM	$852.47M 1.19B AUD 6K%	23.5	Australia
Smartgroup Corporation Ltd. ASX: SIQ	$839.87M 1.18B AUD 6K%	14.7	Australia
Cuscal Ltd. ASX: CCL	$683.29M 957.49M AUD 5K%	24.5	Australia

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 1M%	129.8	Canada
Verisure plc STO: VSURE	$133.15B 114.8B EUR 966K%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 505K%	36.8	United States
RELX PLC LSE: REL	$63.87B 47.6B GBP 463K%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 333K%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 303K%	-	Canada

chevron_leftBack